Though PD-1 interacts with both PD-L1 and PD-L2 expressed by tumor cells and tumor stroma, only PD-L1 is the dominant inhibitory ligand of PD-1 on T cells in human TME [95,96,97]. This evidence concerns the gene PDCD1 and neoplasm.